The global Mecobalamin Market is projected to grow substantially over the forecast period, reaching US$ 2.78 billion by 2034 from US$ 1.28 billion in 2025, registering a robust CAGR of 8.98% during 2026–2034. Mecobalamin, an active form of vitamin B12, has gained significant importance in the treatment of peripheral neuropathy, megaloblastic anemia, diabetic neuropathy, and various...
Italiano 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt